Shaaban, Abeer M. http://orcid.org/0000-0001-5784-8705
,
Hilton, Bridget
Clements, Karen
Provenzano, Elena
Cheung, Shan
Wallis, Matthew G.
Sawyer, Elinor http://orcid.org/0000-0001-8285-4111
Thomas, Jeremy S.
Hanby, Andrew M.
Pinder, Sarah E. http://orcid.org/0000-0003-4167-8910
Thompson, Alastair M.
Funding for this research was provided by:
Cancer Research UK and by KWF Kankerbestrijding
Article History
Received: 26 April 2020
Revised: 28 September 2020
Accepted: 21 October 2020
First Online: 17 November 2020
Ethics approval and consent to participate
: Ethics Committee approval was not required for this study, originally conducted under the NHS Cancer Screening Programme’s application to the Patient Information Advisory Group (PIAG). More recently, the study has been permitted to process personally identifiable data without consent under Regulation 5 of Statutory Instrument 2002 No. 1438: The Health Service (Control of Patient Information) Regulations 2002 (15/CAG/0207) in line with the following clause: ‘quality assuring screening services to ensure they are effective and safe, and that any incidents are investigated and managed appropriately’. This statutory exemption to common law permits Public Health England to process personally identifiable data for activities it is ‘responsible and accountable to the Secretary of State for Health for’, as part of its core remit for population screening.
: All authors gave consent for publication.
: Data are held by Public Health England. Access to the Sloane Project data from external parties is governed by consultation with the Sloane Project Steering Group and application to Public Health England’s breast screening research advisory committee (RAC) and Public Health England’s office for data release (ODR). Data will subsequently only be released by Public Health England to researchers under approval and in an anonymised or depersonalised format, with a data sharing contract in place.
: The authors declare no competing interests.
: This work was supported by Public Heath England and, in part, by Cancer Research UK and by KWF Kankerbestrijding (ref. C38317/A24043) who provided funding support for K.C., E.S., A.M.T. and S.E.P.